Investigating Health, Equity, and Resilience in Girls and Women With ADHD Across the Lifespan

Condition(s) studied

Investigational drug(s) / intervention(s)

No Intervention: Observational Cohort: This is an observational study with no intervention. Participants will only complete self-report questionnaires.

Study summary

The goal of this observational study is to generate a comprehensive, multi-dimensional dataset of health indicators collected from girls and women (aged 10 years and older) with and without ADHD across the lifespan. Participants will be asked to complete a detailed survey about hormonal and developmental life phases, ADHD status and symptoms, childhood experiences, health and well-being, and psychosocial outcomes.

Eligibility

Primary outcome measure(s)

• Self-reported mental health — baseline (upon entry into study)
  Self-reported mental health history (assessed using a study-developed questionnaire querying current depression, anxiety, OCD, bipolar disorder, personality disorders, conduct disorder, oppositional defiant disorder, learning disorders, and other mental health challenges, as well as medication use for these conditions). This is a check list of disorders in which participants can self-identify diagnoses. There is no minimum/maximum.
• Depression, anxiety, and stress — baseline (upon entry into study)
  Depression, anxiety, and stress measured using the 18-item Depression Anxiety Stress Scales. Participants are asked to use 4-point severity/frequency scales to rate the extent to which they have experienced each state over the past week. Scores for Depression, Anxiety and Stress are calculated by summing the scores for the relevant items. Higher scores are indicative of greater distress.

Trial sites (1)

More University of Calgary trials in Canada

Other trials for the same condition